Serious anemia or neutropenia occur in nearly 50% of patients infected with human immunodeficiency virus (HIV) who are treated with azido- deoxythymidine (AZT). The pathogenesis of these changes is not well characterized but is likely to involve effects of the virus on hematopoietic progenitors or bone marrow stromal cells that regulate hematopoiesis. The overall objective of this study is to use the naturally occurring and experimentally reproducible model of feline leukemia virus (FeLV)-induced myelosuppression to investigate mechanisms of hematopoietic suppression and to develop methods for effective treatment. Cats with persistent FeLV infection are markedly immunosuppressed and develop a variety of infectious, neoplastic, or myelosuppressive diseases which resemble AIDS. Experimental infection of cats with the Kawakami-Theilen isolate of FeLV results in variable neutropenia and erythroid aplasia.
The specific aims are to investigate the effects of feline leukemia virus on cells of the bone marrow stroma, determine the mechanism and role of stromal cell injury in retrovirus-induced hematopoietic defects, and evaluate potential methods for counteracting the inhibitory effects of retroviruses and AZT on hematopoietic cells. Sequential biopsies of bone marrow will be evaluated for morphologic and cytochemical evidence of infection or injury of critical cells of the bone marrow stroma. Long-term bone marrow cultures, clonal assays for hematopoietic progenitors, and cultures of fibroblastic cells of the bone marrow stroma will be used to investigate mechanisms of retrovirus-mediated inhibition of bone marrow stromal cells. Transplantation of autologous bone marrow cryopreserved prior to infection with FeLV and clonally expanded populations of uninfected autologous bone marrow stromal cells will be used to reconstitute the marrow of infected animals. The pharmacologic induction of endogenous production of hematopoietic growth factors will be evaluated as a method of counteracting the hematopoietic suppression in retrovirus- infected animals being treated with AZT.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK041939-02
Application #
3242941
Study Section
Special Emphasis Panel (SRC (DB))
Project Start
1988-12-20
Project End
1991-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Veterinary Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Rigby, M A; Rojko, J L; Stewart, M A et al. (1992) Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol 73 ( Pt 11):2839-47
Khan, K N; Kociba, G J; Wellman, M L et al. (1992) Cytotoxicity in feline leukemia virus subgroup-C infected fibroblasts is mediated by adherent bone marrow mononuclear cells. In Vitro Cell Dev Biol 28A:260-6
Khan, K N; Kociba, G J; Wellman, M L et al. (1992) Effects of tumor necrosis factor-alpha on normal feline hematopoietic progenitor cells. Exp Hematol 20:900-3
Rojko, J L; Kociba, G J (1991) Pathogenesis of infection by the feline leukemia virus. J Am Vet Med Assoc 199:1305-10
Wellman, M L; Kociba, G J; Mathes, L E (1991) Variable suppression of feline bone marrow fibroblast colony-forming units by two isolates of feline leukemia virus. Am J Vet Res 52:1924-7
Swenson, C L; Polas, P J; Cheney, C M et al. (1991) Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro. Am J Vet Res 52:2010-5
Cheney, C M; Rojko, J L; Kociba, G J et al. (1990) A feline large granular lymphoma and its derived cell line. In Vitro Cell Dev Biol 26:455-63